Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
12%
ALSO IN XPH
XPH
58
HOLDINGS
12%
ALSO IN XLV
SECTOR DRIFT (XLV minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.2% | 2.1% | 2.1% |
|
PFIZER INC | 2.6% | 2.0% | 2.0% |
|
MERCK & CO. INC. | 5.8% | 2.0% | 2.0% |
|
JOHNSON & JOHNSON | 10.1% | 2.0% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 1.8% | 1.8% |
XLV Overweight Relative to XPH
|
ELI LILLY & CO | 13.1% |
|
JOHNSON & JOHNSON | 8.2% |
|
ABBVIE INC | 7.9% |
|
UNITEDHEALTH GROUP INC | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
MERCK & CO. INC. | 3.8% |
|
AMGEN INC | 3.6% |
|
GILEAD SCIENCES INC | 3.0% |
|
ABBOTT LABORATORIES | 2.8% |
|
INTUITIVE SURGICAL INC | 2.4% |
XLV Underweight Relative to XPH
|
VERADERMICS INC | -2.6% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.3% |
 |
PERRIGO CO | -2.1% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |
|
CORCEPT THERAPEUTICS INC | -2.1% |
|
BIOSANTE PHARMACEUTICALS INC | -2.1% |
|
OMEROS CORP | -2.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.0% |
|
ORGANON & CO. | -2.0% |